Based on 2 analysts giving stock ratings to Medifast Inc in the past month.
In the current month, MED has received 0 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MED average Analyst price target in the last month is 12.000.
Based on analysts' estimates, MED EPS is projected to reach -0.350 in FY2026Q3, following reported EPS of -0.278 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
The market expectation was USD -0.28, while Medifast IncMED's earnings per share (EPS) for the previous quarter was USD -0.19. EPS for the next quarter is expected at USD -0.35.